Related Experiment Video
Updated: Aug 6, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
[Malignant fibrous histiocytoma]
1Dental School, Mahidol University.
Malignant fibrous histiocytoma is a rare soft tissue tumor predominantly affecting extremities in older males. Early diagnosis by dentists is crucial due to its aggressive nature and poor prognosis, often involving metastasis.
Area of Science:
- Oncology
- Pathology
- Oral Medicine
Context:
- Malignant fibrous histiocytoma (MFH) is a rare soft tissue neoplasm.
- It predominantly affects the extremities of older adults, with a higher incidence in males.
- While typically found in soft tissues, MFH can also occur in bone, oral soft tissue, and the jaw.
Purpose:
- To inform healthcare professionals, particularly dentists, about the key features of malignant fibrous histiocytoma.
- To emphasize the importance of recognizing MFH in the oral cavity to differentiate it from benign lesions.
- To highlight the need for prompt and accurate diagnosis and appropriate treatment of this aggressive neoplasm.
Summary:
- Malignant fibrous histiocytoma (MFH) is a mesenchymal tumor primarily affecting soft tissues, especially in the extremities.
- Clinical presentation commonly involves a palpable mass and pain, with a predilection for older males.
- The prognosis for MFH is generally poor due to its high metastatic potential to vital organs.
Impact:
- Enhancing dentists' ability to diagnose oral malignant fibrous histiocytoma accurately.
- Facilitating earlier detection and intervention for patients with this aggressive tumor.
- Improving patient outcomes by enabling timely and correct management of malignant fibrous histiocytoma.
More Related Videos
06:15Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
04:04Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025